Bullous pemphigoid and multiple myeloma: a case report
DOI:
https://doi.org/10.32385/rpmgf.v38i6.13199Keywords:
Bullous skin diseases, Bullous pemphigoid, Malignancy, Multiple myeloma, Care reportAbstract
Introduction: Autoimmune bullous skin diseases are rare pathologies. Among these, bullous pemphigoid is the most common subepidermal autoimmune bullous disease. The concomitant occurrence of bullous pemphigoid and malignancy has been reported in the literature, however, the evidence of this association remains controversial. This case report aims to raise awareness of this pathology’s existence, and its possible association with malignancy, and highlight the importance of several characteristics of general practice/family medicine.
Case description: A 73-year-old woman with a history of diabetes mellitus, high blood pressure, and recurrent depressive disorder. No alcoholic, smoking, or toxiphilic habits. She constitutes a unitary family. Throughout several medical appointments, she presented with skin lesions (initially nonspecific lesions and later on tense bullous lesions), associated with pruritus, constitutional symptoms, and anemia, which started almost at the same time. Diagnoses of bullous pemphigoid and multiple myeloma were made. She was treated with oral corticosteroid therapy and has achieved complete resolution of the cutaneous symptoms. She later started chemotherapy and that improved her constitutional symptoms. She remains autonomous, living alone, with good family support.
Comment: Bullous pemphigoid is a skin condition that family physicians should be aware of. Its possible association with malignancy is not proven. However, in patients with a recent diagnosis of bullous pemphigoid, although the search for neoplasms cannot be recommended beyond the usual oncological screenings, we suggest that a comprehensive assessment should be carried out, especially if there are suspicious signs and symptoms. The exposed clinical case also highlights the importance of all the characteristics of general practice/family medicine.
Downloads
References
Pezzolo E, Naldi L. Epidemiology of major chronic inflammatory immune-related skin diseases in 2019. Expert Rev Clin Immunol. 2020;16(2):155-66.
Yang M, Wu H, Zhao M, Chang C, Lu Q. The pathogenesis of bullous skin diseases. J Transl Autoimmun. 2019;2:100014.
Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28(9):1133-40.
Kalińska-Bienias A, Kowalczyk E, Jagielski P, Bienias P, Kowalewski C, Wozniak K. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: case-control study in a specialized Polish center. Adv Clin Exp Med. 2019;28(5):637-42.
Balestri R, Magnano M, La Placa M, Patrizi A, Angileri L, Tengattini V, et al. Malignancies in bullous pemphigoid: a controversial association. J Dermatol. 2016;43(2):125-33.
Jedlickova H, Hlubinka M, Pavlik T, Semradova V, Budinska E, Vlasin Z. Bullous pemphigoid and internal diseases: a case-control study. Eur J Dermatol. 2010;20(1):96-101.
Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017;18(4):513-28.
Allen J, Gay B, Crebolder H, Heyrman J, Svab I, Ram P, et al. A definição Europeia de medicina geral e familiar (clínica geral/medicina familiar) [The European definition of family medicine (general practice/family medicine). Rev Port Clin Geral. 2005;21(5):511-6. Portuguese
Lucariello RJ, Villablanca SE, Mascaró Jr JM, Reichel M. Association between bullous pemphigoid and malignancy: a meta-analysis. Australas J Dermatol. 2018;59(4):253-60.
Atzmony L, Mimouni I, Reiter O, Leshem YA, Taha O, Gdalevich M, et al. Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(4):691-9.
Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai Y, Imamura S, et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci. 1995;9(2):136-41.
Wright B, Halper K, Worswick S. Bullous pemphigoid and malignancy in two different hospital populations: a retrospective cohort review. Oncology. 2020;98(5):318-20.
Lindelöf B. Pemphigoid and cancer. Arch Dermatol. 1990;126(1):66-8.
Harati A, Brockmeyer NH, Altmeyer P, Kreuter A. Skin disorders in association with monoclonal gammopathies. Eur J Med Res. 2005;10(3):93-104.
Wong DA, Hunt MJ, Stapleton K. IgA multiple myeloma presenting as an acquired bullous disorder. Australas J Dermatol. 1999;40(1):31-4.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
